A less invasive assay to quantify lamin A and progerin in HGPS-patient blood is still under development; nevertheless, the evidence presented here establishes the feasibility of detecting these proteins in blood. This evidence concerns the gene LMNA and Hutchinson-Gilford progeria syndrome.